Page 29 - Anjali Singh

CDSCO centralises GMP issuance and verification with new online portal

This initiative addresses long-standing concerns over inconsistent certificate formats and verification challenges across India's 28 states

India pharma exports surge 9%, outpacing global average, says report

India has also surpassed the US in the number of FDA-registered generic manufacturing sites

DCGI streamlines drug export approval, plans revised biosimilar guidelines

Previously, companies exporting drugs from India had to apply for a customer- and quantity-specific NOC each time they received an order

Indian pharma sector's regulatory violation instances fell 11% in '24

In 2014, the share of OAI status globally stood at 6 per cent which has now more than doubled standing at 14 per cent

MO Alts acquires majority stake in Megafine Pharma for Rs 460 crore

Megafine currently operates two USFDA-approved manufacturing facilities located in Nashik, Maharashtra, and Vapi, Gujarat, and specialises in niche, high-margin APIs, primarily used in chronic disease

India's CRDMO sector looks to expand, looks to touch $25 bn by 2035: Report

This surge is also being driven by India's cost advantages compared to Western countries, 90 per cent faster project startup times, and global supply chain realignments

Amgen opens $200 million technology and innovation hub in Hyderabad

The facility, which occupies approximately 524,000 square feet across two towers in HITEC City, will focus on harnessing AI, data science, and digital innovation to accelerate research and development

Global survey reveals low awareness of shingles among older Indians

Shingles, caused by the reactivation of the varicella-zoster virus-the same virus responsible for chickenpox-is a painful disease that can lead to severe and long-lasting complications

CEAT Specialty expands globally, targets 70-30 export-domestic split

Company's expansion move is linked to its decision to acquire Camso, a global leader in OHT solutions

Sun Pharmaceutical seeks shareholder nod for RPTs worth $1 billion

A key component of the transactions includes a $650 million funding arrangement for its U.S. subsidiary, Sun Pharmaceutical Industries Inc. (SPI Inc.), to support business expansion

Automotive component industry likely to grow 8-10% in FY26, says ICRA

Credit rating agency ICRA forecasts that this growth will be driven by strong export performance, increasing localisation of electric vehicle (EV) components, and rising demand in the aftermarket

Birla Fertility & IVF targets global expansion, doubling India centres

This move aligns with the company's aggressive domestic expansion, where it plans to double its centres across India from the current 50 to 100, backed by an investment of Rs 500 crore

Audi India bets on EVs for growth in India as supply chain issues ease

In a recent discussion, the company confirmed that while supply chain disruptions previously affected availability, the situation has now stabilised

Eyecare hospital chain MaxiVision plans expansion in Maharashtra, eyes IPO

MaxiVision is also setting its sights on the stock market, with plans to go public within the next two years

Tata.ev plans to double India's EV charge points to 400,000 by 2027

Already charger utilisation levels have increased in India with the growing population of EVs

Jubilant Biosys expands global footprint with acquisition in France

This acquisition marks a significant step in Jubilant Biosys' global strategy, providing a foothold in Europe's expanding pharmaceutical and biotech ecosystem

Mumbai reports first GBS death as Maharashtra toll climbs to eight

The patient, who was a resident of the Wadala area, was admitted to BMC-run Nair Hospital on January 23, 2025, after experiencing weakness in his legs

Simple Energy unveils upgraded electric scooter, seeks aggressive expansion

Bengaluru-based EV startup says its product is India's longest-range electric scooter

Apollo Hospital Q3FY25 results: Profit rises 51%, revenue soars 13.9%

Overall hospital occupancy rose to 68 per cent from 66 per cent last year, driven by increased patient volume

Visa relaxation shot in the arm after Bangladesh medical tourists dipped

Between April and September 2024-25, major players reported an almost 25-40 per cent decline in medical tourist flow from Bangladesh